Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings symbols : NVSEF save search
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
XNCR | $18.65 -1.58% 130K
|
Health Technology
|
| O: -0.66%
H: 4.19%
C: 3.13%
MOR | $17.96 -0.5% 72K
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -0.93%
INCY | $52.45 -0.7% 530K
|
Health Technology
|
| O: 0.03%
H: 1.47%
C: -0.72%
year update financial results
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company
Published: 2023-08-23 (Crawled : 12:00) - biospace.com/
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.56%
H: 0.1%
C: -0.32%
growth
TScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Upcoming Milestones
Published: 2023-03-08 (Crawled : 14:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.45%
H: 0.0%
C: 0.0%
TCRX 1 d | $6.99 1.01% 58K
|
Professional, Scientific, and T...
|
| O: -2.73%
H: 6.07%
C: 3.43%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.4%
H: 0.32%
C: -0.42%
year therapeutics financial results
BeiGene Reports Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-02-27 (Crawled : 14:00) - biospace.com/
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.64%
H: 0.01%
C: -0.72%
BGNE | $130.63 -1.01% 69K
|
Health Technology
|
| O: -2.82%
H: 5.13%
C: 3.11%
year financial results
Blueprint Medicines Reports Fourth Quarter and Full Year 2022 Results
Published: 2023-02-16 (Crawled : 18:00) - biospace.com/
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -1.48%
H: 0.55%
C: 0.08%
BPMC | News | $87.16 -1.96% 130K
|
Health Technology
|
| O: 2.02%
H: 2.36%
C: -0.47%
year results
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.27%
H: 0.0%
C: 0.0%
TAK | News | $13.185 0.19% 430K
|
Health Technology
|
| O: -0.13%
H: 1.01%
C: 0.89%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.29%
H: 0.86%
C: 0.72%
XNCR | $18.65 -1.58% 130K
|
Health Technology
|
| O: -0.19%
H: 1.15%
C: -2.27%
MOR | $17.96 -0.5% 72K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -0.59%
INCY | $52.45 -0.7% 530K
|
Health Technology
|
| O: -1.02%
H: 0.29%
C: -3.04%
financial
Precision BioSciences Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-08 (Crawled : 13:00) - biospace.com/
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.54%
H: 1.08%
C: 0.57%
SWTX | News | $40.555 -4.51% 180K
|
Health Technology
|
| O: 1.64%
H: 4.18%
C: -1.53%
DTIL | $9.985 -6.86% 93K
|
Health Technology
|
| O: -0.81%
H: 6.5%
C: 3.25%
financial update results
REGENXBIO Reports Third Quarter 2022 Financial Results and Recent Operational Highlights
Published: 2022-11-03 (Crawled : 12:20) - biospace.com/
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.82%
H: 0.83%
C: 0.56%
QURE | $4.67 -0.85% 64K
|
Health Technology
|
| O: -2.13%
H: 4.15%
C: -0.56%
RARE F | $43.45 0.16% 67K
|
Health Technology
|
| O: 0.25%
H: 3.17%
C: -6.19%
RCKT M | $23.33 -0.64% 110K
|
Health Technology
|
| O: -1.88%
H: 4.96%
C: 0.17%
RGNX | $15.925 -1.15% 120K
|
Health Technology
|
| O: -3.01%
H: 0.77%
C: -10.46%
financial results
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
TAK | News | $13.185 0.19% 430K
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.47%
H: 0.09%
C: -0.55%
XNCR | $18.65 -1.58% 130K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: -0.11%
MOR | $17.96 -0.5% 72K
|
Health Technology
|
| O: 3.1%
H: 1.8%
C: -0.6%
INCY | $52.45 -0.7% 530K
|
Health Technology
|
| O: 1.59%
H: 7.26%
C: 1.89%
financial results
Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-08-02 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
TAK | News | $13.185 0.19% 430K
|
Health Technology
|
| O: -1.33%
H: 0.78%
C: -1.06%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
XNCR | $18.65 -1.58% 130K
|
Health Technology
|
| O: -0.32%
H: 5.09%
C: 3.9%
MOR | $17.96 -0.5% 72K
|
Health Technology
|
| O: -3.37%
H: 3.3%
C: 0.92%
INCY | $52.45 -0.7% 530K
|
Health Technology
|
| O: -4.39%
H: 0.2%
C: -1.92%
results
Baxter Reports Second-Quarter 2022 Results
Published: 2022-07-28 (Crawled : 12:20) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.12%
H: 2.36%
C: 2.36%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.02%
H: 0.99%
C: 0.56%
BAX | $39.545 -0.27% 690K
|
Health Technology
|
| O: -7.56%
H: 1.47%
C: -3.64%
results
BeiGene Reports First Quarter 2022 Financial Results
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.39%
H: 0.15%
C: -1.07%
BGNE | $130.63 -1.01% 69K
|
Health Technology
|
| O: 0.98%
H: 7.7%
C: -2.09%
results
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
XNCR | $18.65 -1.58% 130K
|
Health Technology
|
| O: 2.08%
H: 1.96%
C: -0.77%
MOR | $17.96 -0.5% 72K
|
Health Technology
|
| O: 2.45%
H: 0.92%
C: -2.03%
INCY | $52.45 -0.7% 530K
|
Health Technology
|
| O: 2.12%
H: 4.06%
C: 1.39%
results
REGENXBIO Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Operational Highlights
Published: 2022-03-01 (Crawled : 22:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.9%
H: 0.0%
C: -1.59%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 1.3%
H: 0.0%
C: 0.0%
RARE F | $43.45 0.16% 67K
|
Health Technology
|
| O: -0.42%
H: 2.66%
C: 0.49%
RCKT M | $23.33 -0.64% 110K
|
Health Technology
|
| O: 0.56%
H: 0.22%
C: -6.92%
RGNX | $15.925 -1.15% 120K
|
Health Technology
|
| O: 0.34%
H: 2.79%
C: 0.57%
financial results report results
BeiGene Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-25 (Crawled : 12:30) - biospace.com/
ZYME | $8.84 1.96% 160K
|
Health Technology
|
| O: 2.5%
H: 0.0%
C: 0.0%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
BGNE | $130.63 -1.01% 69K
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
financial results report results
Baxter Reports Fourth-Quarter and Full-Year 2021 Results
Published: 2022-02-17 (Crawled : 13:00) - biospace.com/
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -1.01%
H: 0.2%
C: -0.45%
BAX | $39.545 -0.27% 690K
|
Health Technology
|
| O: -5.09%
H: 3.7%
C: 2.48%
report results
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
TAK | News | $13.185 0.19% 430K
|
Health Technology
|
| O: 0.49%
H: 0.56%
C: -0.07%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.3%
H: 0.15%
C: -0.4%
XNCR | $18.65 -1.58% 130K
|
Health Technology
|
| O: 2.7%
H: 1.01%
C: 0.85%
MOR | $17.96 -0.5% 72K
|
Health Technology
|
| O: 3.75%
H: 1.22%
C: 1.22%
INCY | $52.45 -0.7% 530K
|
Health Technology
|
| O: -1.93%
H: 0.19%
C: -3.14%
financial results results
Baxter Reports Third-Quarter 2021 Results
Published: 2021-10-28 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.79%
H: 0.6%
C: 0.6%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.66%
H: 0.76%
C: 0.04%
BAX | $39.545 -0.27% 690K
|
Health Technology
|
| O: 0.46%
H: 2.41%
C: -4.51%
results
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.